Cellectis S.A. Files 6-K Report

Ticker: CLLS · Form: 6-K · Filed: Apr 10, 2024 · CIK: 1627281

Cellectis S.A. 6-K Filing Summary
FieldDetail
CompanyCellectis S.A. (CLLS)
Form Type6-K
Filed DateApr 10, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, press-release

TL;DR

Cellectis filed a 6-K with a press release on 4/10. Check for updates.

AI Summary

Cellectis S.A. filed a Form 6-K on April 10, 2024, reporting a press release dated April 10, 2024. The filing is for a foreign private issuer and indicates that the company files annual reports under Form 20-F. The principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.

Why It Matters

This filing serves as an official notification to the SEC and investors about the company's reporting status and includes a press release, which may contain material updates.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that primarily serves to submit a press release and confirm reporting status, without disclosing new financial or operational material events.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2024, and includes a press release dated April 10, 2024.

Does Cellectis S.A. file annual reports under Form 20-F or 40-F?

Cellectis S.A. indicates by check mark that it files annual reports under cover of Form 20-F.

What is the Commission File Number for Cellectis S.A.?

The Commission File Number for Cellectis S.A. is 001-36891.

Where is Cellectis S.A.'s principal executive office located?

Cellectis S.A.'s principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.

What exhibit is included with this 6-K filing?

The filing includes Exhibit 99.1, titled 'Press Release dated April 10, 2024'.

Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.6 · Accepted 2024-04-10 16:35:26

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: April 10, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing